600566: Hubei Jumpcan Pharmaceutical Co., Ltd. - Summary | Jitta

Hubei Jumpcan Pharmaceutical Co., Ltd.

CHN:600566

Price
CN¥27.69
Loss Chance
47.5%
5.52JITTA SCORE
71.90%Over Jitta Line
Jitta Ranking
255 / 487
2,426 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (64)
Financial Strength (80)
Return to Shareholders (62)
Competitive Advantage (60)
Jitta Signs
Operating MarginExpansion
Debt LevelLow Long Term Debt
CapExVery Low
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Revenue and EarningRevenue decline from 2022-2025
Recent Business PerformanceEarning decline 26.08% in the last year
Key Stats
Jitta Score
Jitta Line
5.52
71.90%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, hemostasis, gynecology, pneumology, gastroenterology, and geriatrics. The company is headquartered in Taixing, China.